[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:glycogen-storage-disease-type-ii":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":77,"states":78},"Glycogen Storage Disease Type II",11,10,[8,16,22,28,34,40,46,52,58,64,70],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04808505","A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa\u002FMiglustat in IOPD Subjects Aged 0 to \u003C18",[12],"Phase 3","RECRUITING","2026-08-26T02:17:11.311767Z","2026-05-05T02:43:27.746082Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07478172","Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease",[],"2026-08-26T02:18:04.640417Z","2026-04-29T02:57:57.124114Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06121011","A Global Prospective Observational Registry of Patients With Pompe Disease",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.416937Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05734521","Avalglucosidase Alfa Pregnancy Study",[],"2026-08-26T02:16:10.529598Z","2026-05-13T02:55:06.373590Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT04639336","Cognitive and Neurological Pathologies in Pompe Disease",[],"2026-08-26T02:19:09.651016Z","2026-05-13T02:55:06.256405Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT01665326","Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease",[],"2026-08-26T02:17:24.721169Z","2026-05-13T02:55:06.075434Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT00567073","Pompe Pregnancy Sub-Registry",[],"2026-08-26T02:18:26.129155Z","2026-05-13T02:55:06.037723Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT00231400","Pompe Disease Registry Protocol",[],"2026-08-26T02:15:53.461103Z","2026-05-13T02:55:06.032941Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":62,"content_modified":63},"NCT06539169","FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases",[],"2026-08-26T02:18:44.395098Z","2026-05-13T02:55:06.551987Z",{"nct_id":65,"title":66,"phases":67,"status":13,"updated_at":68,"content_modified":69},"NCT05619900","Registry of Patients Diagnosed With Lysosomal Storage Diseases",[],"2026-08-26T02:15:47.754948Z","2026-05-13T02:55:06.364859Z",{"nct_id":71,"title":72,"phases":73,"status":74,"updated_at":75,"content_modified":76},"NCT03655223","Early Check: Expanded Screening in Newborns",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:53:57.297126Z","2026-06-16T05:54:07.977837Z",[],[79,83,87,90,93,96,99,103,106,109,112],{"state":80,"count":81,"slug":82},"North Carolina",7,"north-carolina",{"state":84,"count":85,"slug":86},"California",4,"california",{"state":88,"count":85,"slug":89},"Florida","florida",{"state":91,"count":85,"slug":92},"Georgia","georgia",{"state":94,"count":85,"slug":95},"Missouri","missouri",{"state":97,"count":85,"slug":98},"Ohio","ohio",{"state":100,"count":101,"slug":102},"Indiana",3,"indiana",{"state":104,"count":101,"slug":105},"New York","new-york",{"state":107,"count":101,"slug":108},"Pennsylvania","pennsylvania",{"state":110,"count":101,"slug":111},"Utah","utah",{"state":113,"count":101,"slug":114},"Virginia","virginia"]